Header Logo

Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by CHARLES F LEVENBACK and THOMAS W BURKE.
CHARLES F LEVENBACK
Connection Strength
1.253
THOMAS W BURKE
  1. Enterovesical fistula following radiotherapy for gynecologic cancer. Gynecol Oncol. 1994 Mar; 52(3):296-300.
    View in: PubMed
    Score: 0.119
  2. Lymphatic mapping and sentinel node biopsy in women with high-risk endometrial cancer. Gynecol Oncol. 2007 Jan; 104(1):100-3.
    View in: PubMed
    Score: 0.071
  3. Characteristics of recurrence in patients who underwent lymphatic mapping for vulvar cancer. Gynecol Oncol. 2004 Jan; 92(1):205-10.
    View in: PubMed
    Score: 0.059
  4. Groin recurrence in patients with vulvar cancer with negative nodes on superficial inguinal lymphadenectomy. Gynecol Oncol. 2003 Sep; 90(3):625-8.
    View in: PubMed
    Score: 0.057
  5. Mixed choriocarcinoma in a postmenopausal patient. Int J Gynecol Cancer. 2002 May-Jun; 12(3):312-6.
    View in: PubMed
    Score: 0.052
  6. Lymphatic mapping and sentinel node identification in patients with cervix cancer undergoing radical hysterectomy and pelvic lymphadenectomy. J Clin Oncol. 2002 Feb 01; 20(3):688-93.
    View in: PubMed
    Score: 0.051
  7. Intraoperative lymphatic mapping and sentinel node identification with blue dye in patients with vulvar cancer. Gynecol Oncol. 2001 Nov; 83(2):276-81.
    View in: PubMed
    Score: 0.051
  8. Arterial occlusion complicating treatment of gynecologic cancer: a case series. Gynecol Oncol. 1996 Oct; 63(1):40-6.
    View in: PubMed
    Score: 0.036
  9. Transverse colon urinary diversion in gynecologic oncology. Gynecol Oncol. 1996 Oct; 63(1):66-70.
    View in: PubMed
    Score: 0.036
  10. Intraabdominal lymphatic mapping to direct selective pelvic and paraaortic lymphadenectomy in women with high-risk endometrial cancer: results of a pilot study. Gynecol Oncol. 1996 Aug; 62(2):169-73.
    View in: PubMed
    Score: 0.035
  11. Groin dissection practices among gynecologic oncologists treating early vulvar cancer. Gynecol Oncol. 1996 Jul; 62(1):73-7.
    View in: PubMed
    Score: 0.035
  12. A comparison of end and loop colostomy for fecal diversion in gynecologic patients with colonic fistulas. Gynecol Oncol. 1996 Jan; 60(1):49-53.
    View in: PubMed
    Score: 0.034
  13. Potential applications of intraoperative lymphatic mapping in vulvar cancer. Gynecol Oncol. 1995 Nov; 59(2):216-20.
    View in: PubMed
    Score: 0.033
  14. Surgical therapy of T1 and T2 vulvar carcinoma: further experience with radical wide excision and selective inguinal lymphadenectomy. Gynecol Oncol. 1995 May; 57(2):215-20.
    View in: PubMed
    Score: 0.032
  15. Perineal reconstruction using single gracilis myocutaneous flaps. Gynecol Oncol. 1995 May; 57(2):221-5.
    View in: PubMed
    Score: 0.032
  16. Intestinal fistulae formation following pelvic exenteration: a review of the University of Texas M. D. Anderson Cancer Center experience, 1957-1990. Gynecol Oncol. 1995 Feb; 56(2):207-10.
    View in: PubMed
    Score: 0.032
  17. Closure of complex vulvar defects using local rhomboid flaps. Obstet Gynecol. 1994 Dec; 84(6):1043-7.
    View in: PubMed
    Score: 0.031
  18. Hemorrhagic cystitis following radiotherapy for stage Ib cancer of the cervix. Gynecol Oncol. 1994 Nov; 55(2):206-10.
    View in: PubMed
    Score: 0.031
  19. Salvage surgery for chemorefractory ovarian germ cell tumors. Gynecol Oncol. 1994 Nov; 55(2):217-23.
    View in: PubMed
    Score: 0.031
  20. Postoperative adjuvant cisplatin, doxorubicin, and cyclophosphamide (PAC) chemotherapy in women with high-risk endometrial carcinoma. Gynecol Oncol. 1994 Oct; 55(1):47-50.
    View in: PubMed
    Score: 0.031
  21. Intraoperative lymphatic mapping for vulvar cancer. Obstet Gynecol. 1994 Aug; 84(2):163-7.
    View in: PubMed
    Score: 0.031
  22. Treatment of advanced or recurrent endometrial carcinoma with single-agent carboplatin. Gynecol Oncol. 1993 Dec; 51(3):397-400.
    View in: PubMed
    Score: 0.029
  23. Uterine papillary serous carcinoma (UPSC) treated with cisplatin, doxorubicin, and cyclophosphamide (PAC). Gynecol Oncol. 1992 Sep; 46(3):317-21.
    View in: PubMed
    Score: 0.027
  24. Phase II trial of imatinib mesylate in patients with recurrent platinum- and taxane-resistant epithelial ovarian and primary peritoneal cancers. Gynecol Oncol. 2006 Apr; 101(1):126-31.
    View in: PubMed
    Score: 0.017
  25. Analysis of 96 patients with advanced ovarian carcinoma treated with high-dose chemotherapy and autologous stem cell transplantation. Bone Marrow Transplant. 2004 Jun; 33(12):1219-24.
    View in: PubMed
    Score: 0.015
  26. A phase II trial of cisplatin, ifosfamide, and mesna in patients with advanced or recurrent uterine malignant mixed m?llerian tumors with evaluation of potential molecular targets. Gynecol Oncol. 2003 Sep; 90(3):529-36.
    View in: PubMed
    Score: 0.014
  27. High-dose topotecan, melphalan, and cyclophosphamide (TMC) with stem cell support: a new regimen for the treatment of advanced ovarian cancer. Gynecol Oncol. 2001 Sep; 82(3):420-6.
    View in: PubMed
    Score: 0.012
  28. Sigmoid perforation following radiation therapy in patients with cervical cancer. Gynecol Oncol. 2001 Jul; 82(1):150-5.
    View in: PubMed
    Score: 0.012
  29. Treatment of uterine papillary serous carcinoma with paclitaxel. Gynecol Oncol. 2001 Jul; 82(1):156-61.
    View in: PubMed
    Score: 0.012
  30. High-dose ifosfamide and etoposide with filgrastim for stem cell mobilization in patients with advanced ovarian cancer. Bone Marrow Transplant. 2000 Jun; 25(11):1137-40.
    View in: PubMed
    Score: 0.011
  31. A phase I trial of intravenous melphalan, paclitaxel, and cisplatin plus granulocyte-colony stimulating factor in patients with suboptimal advanced epithelial ovarian carcinoma or peritoneal carcinoma. Cancer. 1999 Dec 01; 86(11):2291-300.
    View in: PubMed
    Score: 0.011
  32. Radiation treatment of advanced or recurrent granulosa cell tumor of the ovary. Gynecol Oncol. 1999 Apr; 73(1):35-41.
    View in: PubMed
    Score: 0.011
  33. A phase II study of prolonged oral etoposide in advanced or recurrent carcinoma of the cervix. Gynecol Oncol. 1998 Aug; 70(2):215-8.
    View in: PubMed
    Score: 0.010
  34. Phase II study of vinorelbine in advanced and recurrent squamous cell carcinoma of the cervix. J Clin Oncol. 1998 Mar; 16(3):1094-8.
    View in: PubMed
    Score: 0.010
  35. An outcomes management program in gynecologic oncology. Obstet Gynecol. 1997 Apr; 89(4):485-92.
    View in: PubMed
    Score: 0.009
  36. Prognostic significance of residual disease in patients with stage IV epithelial ovarian cancer. Gynecol Oncol. 1997 Jan; 64(1):13-7.
    View in: PubMed
    Score: 0.009
  37. Sexual adjustment of patients undergoing gracilis myocutaneous flap vaginal reconstruction in conjunction with pelvic exenteration. Cancer. 1996 Nov 15; 78(10):2229-35.
    View in: PubMed
    Score: 0.009
  38. Adenocarcinoma in situ of the cervix: significance of cone biopsy margins. Obstet Gynecol. 1996 Jul; 88(1):82-6.
    View in: PubMed
    Score: 0.009
  39. Treatment of poor-prognosis sex cord-stromal tumors of the ovary with the combination of bleomycin, etoposide, and cisplatin. Obstet Gynecol. 1996 Apr; 87(4):527-31.
    View in: PubMed
    Score: 0.009
  40. Surveillance for recurrent endometrial carcinoma: development of a follow-up scheme. Gynecol Oncol. 1995 Nov; 59(2):221-5.
    View in: PubMed
    Score: 0.008
  41. Salvage chemotherapy for refractory transitional cell carcinoma of the ovary (TCC). Gynecol Oncol. 1995 Nov; 59(2):211-5.
    View in: PubMed
    Score: 0.008
  42. Prolonged continuous infusion cisplatin and 5-fluorouracil with radiation for locally advanced carcinoma of the vulva. Gynecol Oncol. 1995 Oct; 59(1):51-6.
    View in: PubMed
    Score: 0.008
  43. Combined cisplatin and carboplatin chemotherapy for treatment of advanced epithelial ovarian cancer. Gynecol Oncol. 1995 Sep; 58(3):349-55.
    View in: PubMed
    Score: 0.008
  44. Staging laparotomy for endometrial carcinoma: assessment of retroperitoneal lymph nodes. Gynecol Oncol. 1995 Aug; 58(2):189-93.
    View in: PubMed
    Score: 0.008
  45. Pelvic exenteration for primary and recurrent vulvar cancer. Gynecol Oncol. 1995 Aug; 58(2):202-5.
    View in: PubMed
    Score: 0.008
  46. Infusion site soft-tissue injury after paclitaxel administration. Cancer. 1995 Jul 01; 76(1):116-20.
    View in: PubMed
    Score: 0.008
  47. Ovarian malignant mixed m?llerian tumors treated with platinum-based chemotherapy. Obstet Gynecol. 1995 May; 85(5 Pt 1):735-9.
    View in: PubMed
    Score: 0.008
  48. Treatment of locally advanced cervical cancer with concurrent radiation and intra-arterial chemotherapy. Gynecol Oncol. 1995 Apr; 57(1):72-8.
    View in: PubMed
    Score: 0.008
  49. Salvage surgery for chemorefractory gestational trophoblastic disease. J Clin Oncol. 1994 Dec; 12(12):2737-42.
    View in: PubMed
    Score: 0.008
  50. A phase II study of carboplatin and cisplatin in advanced or recurrent squamous carcinoma of the uterine cervix. Gynecol Oncol. 1994 May; 53(2):234-8.
    View in: PubMed
    Score: 0.008
  51. Immunocytochemical analysis of uterine papillary serous carcinomas for estrogen and progesterone receptors. Int J Gynecol Pathol. 1994 Apr; 13(2):127-30.
    View in: PubMed
    Score: 0.007
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.